Table 1 Patients baseline characteristics between both groups
Parameter | SOX (n, %) | PTXS (n, %) | P value |
|---|---|---|---|
Sex | Â | Â | 0.114 |
 Male | 62 (80.5) | 17 (65.4) |  |
 Female | 15 (19.5) | 9 (34.6) |  |
Age (years) | Â | Â | 0.835 |
 Median (range) | 59 (24–74) | 61 (29–74) |  |
Body mass index (kg/m2) | Â | Â | 0.866 |
 Median (range) | 22.4 (15.4–33.6) | 22.8 (16.1–22.8) | |
Tumor location | Â | Â | 0.662 |
 Proximal part | 41 (53.2) | 11 (42.3) |  |
 Middle part | 12 (15.6) | 6 (23.1) |  |
 Distal part | 21 (27.3) | 7 (26.9) |  |
 Diffuse | 2 (3.9) | 2 (7.7) |  |
cT stage (pre-NAC) | Â | Â | 0.737 |
 T3 | 12 (15.6) | 5 (19.2) |  |
 T4 | 65 (84.4) | 21 (80.8) |  |
cN stage (pre-NAC) | Â | Â | 0.083 |
 N0 | 4 (5.2) | 2 (7.7) |  |
 N1 | 33 (42.9) | 10 (38.5) |  |
 N2 | 34 (44.2) | 7 (26.9) |  |
 N3 | 6 (7.7) | 7 (26.9) |  |
cTNM stage (pre-NAC) | Â | Â | 0.865 |
 II | 16 (20.8) | 5 (19.2) |  |
 III | 61 (79.2) | 21 (80.8) |  |
Scope of gastrectomy | Â | Â | 0.84 |
 Partial | 25 (32.5) | 9 (34.6) |  |
 Total | 52 (67.5) | 17 (65.4) |  |